Skip to main content
MITI
OTC Technology

Mitesco Secures Toxic Convertible Note and Issues 2M Shares Amid Cash Crunch

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.05
Mkt Cap
$2.424M
52W Low
$0.023
52W High
$0.398
52W Position info
115% above low
Off High info
87% below high
Rel. Volume
Market data snapshot near publication time

MITI has more than doubled off its 52-week low of $0.023.

Summary

Mitesco raised $25,000 via a toxic convertible note with a variable conversion price, issued 2 million shares for services, and lost a director — all while sitting on $8,000 in cash.


Key Events · Financing and Capital Events · MITI

  • Toxic Convertible Note

    ZSP Capital provided $25,000 via a 10% OID convertible note with a conversion price equal to the lesser of $0.15 or 65% of the lowest 10-day trading price — a structure that can rapidly dilute shareholders as the stock falls.

  • 2M Shares Issued for Services

    Four individuals received 500,000 restricted shares each (2M total) valued at $0.0375/share for TCDC and Robo Agent project work, increasing outstanding shares to approximately 51 million.

  • Director Resignation

    Dr. Jordan Ballencic resigned from the board effective October 6, 2026, citing lack of time; the board will not fill the vacancy due to pending acquisition efforts.

  • Cash Crunch Context

    The financing follows the Q2 10-Q showing only $8,000 in cash and $22.4M in current liabilities, with over 20 million new shares issued after quarter-end.


Analysis · MITI · Technology

Already in critical distress with only $8,000 cash and $22.4M in current liabilities as of its last 10-Q, Mitesco has taken a $25,000 convertible bridge note from ZSP Capital. The note carries a variable conversion price set at 65% of the lowest 10-day trading price — a classic toxic financing structure that can rapidly dilute existing shareholders as the holder converts at ever-lower prices. The company also issued 2 million restricted shares to four individuals for project assistance, pushing the share count to approximately 51 million. A director resigned the same week, and the board will not fill the seat, citing pending acquisition efforts. The combination of distressed financing terms, continued share issuance, and board attrition underscores the company's precarious position.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 36.5% of the 953 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.66%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MITI was trading at $0.05 on OTC in the Technology sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.02 to $0.40. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MITI - Latest Insights

MITI
Aug 18, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.02573
Real-time Price: $0.030 info
Change: +$0.00427 (+17%) info
Market Cap: $1.452M info
MITI
Aug 17, 2026, 4:29 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0263
Real-time Price: $0.030 info
Change: +$0.0037 (+14%) info
Market Cap: $1.452M info
MITI
Aug 10, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.0343
Real-time Price: $0.030 info
Change: -$0.0043 (-13%) info
Market Cap: $1.452M info
MITI
Aug 04, 2026, 7:31 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.035
Real-time Price: $0.030 info
Change: -$0.0050 (-14%) info
Market Cap: $1.452M info
MITI
Jul 21, 2026, 5:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.0975
Real-time Price: $0.030 info
Change: -$0.0675 (-69%) info
Market Cap: $1.452M info